Organization
LENZ Therapeutics
4 clinical trials
Clinical trial
Safety Study: A Multi-Center, Double-Masked Phase 3 Safety Study Evaluation of the Long-Term Safety of LNZ101 in Presbyopic SubjectsStatus: Completed, Estimated PCD: 2024-02-09
Clinical trial
A Multi-Center, Double-Masked Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of PresbyopiaStatus: Completed, Estimated PCD: 2023-12-14
Clinical trial
A Prospective, Single-Center, Open-Label, Study of the Plasma Pharmacokinetics and Safety Following Topical Administration of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With PresbyopiaStatus: Completed, Estimated PCD: 2023-10-03
Clinical trial
A Multi-Center, Double-Masked Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of PresbyopiaStatus: Completed, Estimated PCD: 2023-12-15